hotspot -WSS

hotspot

author：fashion 2025-09-06 02:13:28 - browse：53731

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Methadone doses haven’t kept up in the age of fentanyl

WSS

After traumatic brain injury, life support decisions can use more time

Cell therapy fails to slow type 1 diabetes, but safety is established

Bird flu outbreak in cows is latest avian flu curveball

Q&A: Jennifer Adair on making gene therapy available globally

Medical bills so high, Medicare adding extra digits to claim forms

Getting Alzheimer's drug Leqembi to patients can be a challenge

hotspot

hotspot

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Sports medicine is finally prioritizing gender equality

Orangutan used medicinal plant to treat wound, first time ever seen

Drug repurposing or repositioning? The language matters

Friends ask where James Watson's attitudes about race came from

Heart attack and stroke risk calculators need revising

Drastic changes should bring profitability, startup health insurers say

Psychedelics group wrestles with new pharma identity

Element Biosciences CEO lays out genome sequencing strategy

leisure time

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Element Biosciences CEO lays out genome sequencing strategy

FTC falls short on scrutinizing hospital mergers, study says

Exact Sciences stock tumbles despite strong cancer detection sales

Emergent cuts jobs, executive role in business shake

hotspot

knowledge

knowledge

Wikipedia